A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19
Clinical trial NCT04324996 · UNKNOWN
Trial details
- NCT number
- NCT04324996
- Sponsor
- Chongqing Public Health Medical Center
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-21
- Primary completion
- 2022-02-20
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.